SCHEMBL27486201

SCHEMBL27486201

ClCC#CCN1CCOCC1

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50
ALDH1A1 P00352 4/20 0.46
RECQL P46063 1/20 0.46
LMNA P02545 1/20 0.44
KDM4E B2RXH2 4/20 0.41
TDP1 Q9NUW8 1/20 0.41
HSD17B10 Q99714 1/20 0.39
GLA P06280 1/20 0.37
HTT P42858 1/20 0.37
USP2 O75604 1/20 0.37
HRH3 Q9Y5N1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2155386 0.98 POLB (0.49) POLBGAAALDH1A1RECQLLMNA
SCHEMBL6929250 0.88 POLB (0.59) POLBGAAALDH1A1RECQLLMNA
SCHEMBL6930770 0.81 LMNA (0.70) POLBGAAALDH1A1RECQLLMNA
Hydrochloric Acid SCHEMBL7463444 0.81 POLB (0.46) POLBGAAALDH1A1RECQLLMNA
SCHEMBL1745361 0.78 ALDH1A1 (0.66) POLBGAAALDH1A1RECQLLMNA
SCHEMBL12374731 0.77 ALDH1A1 (0.50) POLBGAAALDH1A1RECQLLMNA
SCHEMBL1469845 0.77 POLB (0.59) POLBGAAALDH1A1RECQLLMNA
SCHEMBL21192307 0.77 POLB (0.50) POLBGAAALDH1A1RECQLLMNA
SCHEMBL17392944 0.77 POLB (0.50) POLBGAAALDH1A1RECQLLMNA
SCHEMBL3274800 0.77 POLB (0.50) POLBGAAALDH1A1RECQLLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260109696-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2026-04-23 US disclosed
US-20260078116-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2026-03-19 US disclosed
CN-1167698-C New N-triazolyl methyl piperazine derivate using as neurokinin receptor antagonistic agent ������ҩ�����޹�˾ 2004-09-22 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078116-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, MCL1 POLB 2668/4885GAA 3755/4885ALDH1A1 3887/4885
US-20260109696-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS KRAS, MYC, NRAS POLB 906/4885GAA 3640/4885ALDH1A1 3241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.